Zhang et al. analyzed cells from pediatric AML patients before and after intensive chemotherapy, demonstrating that a small fraction of CD69 HSC-like cells present at diagnosis possessed the LSC signature and could persist after intensive chemotherapy, arguing a possible correlation between senescence and chemotherapy resistance. Here, CD69 is linked to acute myeloid leukemia.